OS. Kaplan-Meier product-limit estimate of OS among all 426 patients (A) and 343 intermediate- and high-risk patients (B), according to whether they received anthracycline monochemotherapy consolidation (LPA96 study) or risk-adapted consolidation (LPA99 study). P values were calculated with use of the log-rank test.